EFFECT OF CETIRIZINE ON THE INFLAMMATORY CELLS IN MOSQUITO BITES

Citation
A. Karppinen et al., EFFECT OF CETIRIZINE ON THE INFLAMMATORY CELLS IN MOSQUITO BITES, Clinical and experimental allergy, 26(6), 1996, pp. 703-709
Citations number
17
Categorie Soggetti
Allergy,Immunology
ISSN journal
09547894
Volume
26
Issue
6
Year of publication
1996
Pages
703 - 709
Database
ISI
SICI code
0954-7894(1996)26:6<703:EOCOTI>2.0.ZU;2-W
Abstract
Background Mosquito bites frequently cause wealing and delayed papules which appear within a few hours after the bites and may persist for s everal days. Cetirizine is an effective drug against mosquito bites by decreasing wealing and also the size and pruritus of the delayed bite papules. Objectives To characterize inflammatory cells in the delayed mosquito-bite lesions, and to study the effect of cetirizine on the i nflammatory cell response.Methods Twenty-six mosquito-bite sensitive s ubjects received cetirizine 20 mg (14 subjects) or placebo (12 subject s) in a double-blind fashion. Aedes aegypti-bites were given on a fore arm and serial punch biopsies were taken at 2-, 6- and 24 h after the bite exposure. Eosinophils, neutrophils, mast cells, mononuclear cells and T- helper (CD4(+)) and suppressor (CD8(+)) lymphocytes were count ed from dermal infiltrates. Results Eosinophils and neutrophils were f ound already in 2-h bite lesions. Moreover, the number of mononuclear and CD4(+) cells increased significantly (P < 0.01) from 2- to 24-h bi te lesions. Unexpectedly, the overall numbers of eosinophils (P < 0.05 ), mononuclear cells (P < 0.01) and CD4(+) cells (P < 0.01) were signi ficantly higher in the cetirizine-treated subjects compared with the p lacebo-treated subjects. Conclusions The results suggest that the infl ammatory cell response in the delayed mosquito-bite lesions is similar to that occurring in allergic late-phase responses, i.e. an early inf lux of eosinophils, neutrophils and subsequent accumalation of CD4(+) lymphocytes. The reason for the high numbers of eosinophils and CD4(+) cells in the cetirizine-treated subjects is not known.